AKP Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Anika Therapeutics Inc

Watchlist Manager

Watchlist

Price: 12.5 EUR -2.34% Market Closed

Market Cap: €297.6m

A	Anika Therapeutics Inc SWB:AKP	US
K	Kaspi.kz AO F:KKS	KZ
	Bankinter SA MAD:BKT	ES
A	Abercrombie & Fitch Co LSE:0R32	US
M	Meta Platforms Inc XHAM:FB2A	US
C	Christian Dior SE OTC:CHDRY	FR
P	Pfizer Inc DUS:PFE	US
	Nikon Corp F:NKN	JP
S	Sun Communities Inc F:SCZ	US
	Visteon Corp NASDAQ:VC	US

Profitability Summary

Anika Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

59%

Strong 3Y Average Gross Margin

61%

Declining Gross Margin

60% > 59%

Negative Operating Margin

-9%

Negative 3Y Average Operating Margin

-7%

Operating Margin is Increasing

-15% > -9%

Negative Net Margin

-10%

Negative 3Y Average Net Margin

-36%

Net Margin is Increasing

-14% > -10%

Healthy Free Cash Flow Margin

Negative 3Y Average Free Cash Flow Margin

-2%

Free Cash Flow Margin is Increasing

-3% > 1%

Negative ROE

-8%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-7%

Declining ROIC

-8% > -9%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.